Navigation Links
Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
Date:10/7/2010

NEW YORK, Oct. 7 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th edition

http://www.reportlinker.com/p0177971/Co-promotion-and-Co-marketing-Agreements-in-Pharma-Biotech-and-Diagnostics-4th-edition.html

DescriptionThe report provides a detailed understand and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either a right or option to co-promote/market the resultant product of the research collaboration. There are also numerous pure co-promotion/marketing deals whereby the products originator takes on a co-promotion/marketing partner in order to maximize a products presence in the marketplace.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

This report contains over 700 links to online copies of actual co-promotion and co-marketing contract documents as submitted to the Securities Exchange Commission by biopharma companies and their partners.

Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Reportlinker Adds Global Vertebral Compression Fracture Devices Industry
2. Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies
3. Reportlinker Adds US Pharmaceutical Market Overview - Healthcare reform, economic pressures and the patent cliff set to impact Pharma
4. Reportlinker Adds Antidiabetics Market Forecast
5. Reportlinker Adds Global Anti-CD20 Monoclonal Antibodies Industry
6. Reportlinker Adds Global Intravenous (IV) Iron Drugs Industry
7. Reportlinker Adds Global Sleeping Pills Industry
8. Reportlinker Adds Global Immunoassay Systems Industry
9. Reportlinker Adds Global Medical Plastics Industry
10. Reportlinker Adds Global Optoelectronics Industry
11. Reportlinker Adds Global Gas Chromatography Systems Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015 ... the addition of the "Investigation Report on ... offering. Originally discovered by Welfide (Mitsubishi ... Industries, Ltd) as an inflammatory drug, pranoprofen was ... Co., Ltd under the trade name of pranopulin ...
(Date:8/28/2015)... , Aug. 28, 2015 Patterson ... Inc. (Nasdaq: PDCO ), is now an ... announced acquisition of Patterson Medical by Madison Dearborn ... retain its name for a transition period before ... rehabilitation and sports medicine products.  With the focused ...
(Date:8/28/2015)... -- The scientific team of a new biotech ... leading academics in the field of aging Prof. Robert ... extension for model animals - 10 fold for nematodes) has ... diseases, primarily, around the stability and stress resistance of certain ... "Stability analysis of a model gene network links aging, stress ...
Breaking Medicine Technology:Investigation Report on China's Pranoprofen Market, 2010-2019 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3
... 4, 2007 - Molecular Insight,Pharmaceuticals, Inc. (NASDAQ: ... the results of several preclinical studies at,the ... Nuclear Medicine (SNM) in,Washington, D.C. The presentations ... clinical-stage, targeted,radiotherapeutic candidate for the treatment of ...
... ZymoGenetics,Inc. today announced that interim findings were presented ... B-cell chronic,lymphocytic leukemia (B-CLL) at the American Society ... included intravenous,administration of higher doses than had been ... was well-tolerated and biologically,active at all dose levels ...
Cached Medicine Technology:Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting 2Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting 3Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting 4ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 2ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 3
(Date:8/29/2015)... ... 29, 2015 , ... "I have been a licensed physical ... specialize in manual therapy, and my invention will provide headache sufferers a solution ... muscle dysfunction throughout the body." , They developed THE RELIEVER to alleviates headaches, ...
(Date:8/29/2015)... ... August 29, 2015 , ... Next weekend is Labor Day weekend, ... officially ends on September 22nd this year). For IT security personnel, it should also ... which could prove far more costly than a simple headache. , Joe Caruso, founder ...
(Date:8/29/2015)... ... August 29, 2015 , ... Vascular Health Sciences ... sell Arterosil and Arterosil HP, and that all claims and counterclaims have been ... Sciences, LLC (VHS) in the United States District Court for the Southern District ...
(Date:8/28/2015)... ... , ... The Kentucky State Department of Workforce Investment Commissioner Beth Kuhn recently ... for, they are unable to pass the initial drug test and therefore unable to ... order to be able to hire long-term, skilled talent. (1) Will Wesch, Director of ...
(Date:8/28/2015)... ... August 28, 2015 , ... As reported by ... received FDA clearance for results that last for two years, the longest of ... for patients who are looking for a long-lasting, effective solution for their cellulite, according ...
Breaking Medicine News(10 mins):Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3
... to have a higher risk of developing late age-related ... to a report in the July issue of Archives ... Age-related macular degeneration (AMD) [a progressive eye disease that ... leading cause of blindness in the Western world, according ...
... an enzyme that inactivates two tumor-suppressing genes, ultimately triggering ... cells, researchers at The University of Texas M. D. ... the journal Cell. , "This is a completely new ... for clinical intervention," senior author Mien-Chie Hung, Ph.D., professor ...
... August 2007) could lead to a change of paradigm in ... resonance imaging (MRI) is substantially more accurate than mammography in ... now MRI was thought to be hardly suited for the ... at the University of Bonn have now come to a ...
... to rid the brain of the amyloid buildup that plagues ... the method outlined in a paper published online August 12 ... Center show how the bodys natural way of ridding the ... disease. Then the team demonstrated an experimental method in mice ...
... 2007 - In an Editorial, to be published ... http://intl.elsevierhealth.com/journals/joca/ ), published by Elsevier, a panel of ... nonsteroidal anti-inflammatory drugs (NSAIDs) must remain a significant ... osteoarthritis (OA). The Editorial summarizes the outcomes of ...
... to leaders of the U.S. House of Representatives Ways ... of the American College of Physicians (ACP) today expressed ... Act of 2007 (H.R. 3162). Representing 124,000 internal medicine ... medical specialty society in the United States. , ...
Cached Medicine News:Health News:Smoking may strongly increase long-term risk of eye disease 2Health News:Pathway links inflammation, angiogenesis and breast cancer 2Health News:Pathway links inflammation, angiogenesis and breast cancer 3Health News:MRI finds breast cancer before it becomes dangerous 2Health News:MRI finds breast cancer before it becomes dangerous 3Health News:Draining away brain's toxic protein to stop Alzheimer's 2Health News:Draining away brain's toxic protein to stop Alzheimer's 3Health News:Using coxibs and NSAIDs to treat osteoarthritis 2Health News:Support for Children's Health and Medicare Protection Act given to House leaders by ACP 2
The adult underbody blanket is conveniently positioned on the table before the patient arrives to the procedure suite....
The adult blanket provides full coverage for patients of all sizes. The generous size and versatility of these blankets include extra material for the shoulders and feet. The foot drape also reduces ...
The Bair Hugger outpatient blanket makes it easy to give your patients the benefit of prewarming and enhance patient comfort during outpatient procedures....
The full body blanket provides coverage to the entire patient....
Medicine Products: